Medco Study Suggests Genetic Testing Improves Patient Compliance with Statins
October 19, 2011
Medco Study Suggests Genetic Testing Improves Patient Compliance with Statins
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Knowledge of KIF6 Mutation Status Increases Patients' Statin Adherence, Medco Study Finds
March 28, 2012 / Pharmacogenomics Reporter - Future of Celera's KIF6 Test Unclear Amid FDA Rejection, Pending Quest Acquisition
April 27, 2011 / Pharmacogenomics Reporter - Authors of Large Meta-Analysis Predict End of KIF6 Test, but Celera Calls Study Flawed
October 13, 2010 / Pharmacogenomics Reporter - With Medco Around for Dx Shops Developing PGx Tests Independently, Who Needs Pharma?
April 14, 2010 / Pharmacogenomics Reporter - Celera and Medco Join Forces to Study Statin Adherence Following KIF6 Testing
September 23, 2009 / Pharmacogenomics Reporter